Tongyangxiao Lotion for Postoperative Wound Healing After Anal Fistula Surgery
Tongyangxiao Lotion Accelerates Postoperative Wound Healing in Anal Fistula Surgery by Activating the PI3K-Akt-mTOR Pathway
1 other identifier
interventional
115
1 country
1
Brief Summary
This study tests whether a traditional Chinese herbal bath called Tongyangxiao (TYX) lotion helps surgical wounds heal faster in patients who have had anal fistula surgery. Anal fistulas are abnormal tunnels near the anus that often require surgery, but the wound is usually left open and heals slowly. The study compares TYX lotion with a standard antiseptic bath (potassium permanganate). Patients use one of the two baths once daily for 14 days after surgery. The main goal is to see how long it takes for the wound to close completely. The study also measures pain, wound size, inflammation, and proteins involved in healing. A total of 115 patients took part, and laboratory experiments with human skin cells were also performed to understand how TYX works.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedFirst Submitted
Initial submission to the registry
April 26, 2026
CompletedFirst Posted
Study publicly available on registry
May 1, 2026
CompletedMay 1, 2026
April 1, 2026
1.1 years
April 26, 2026
April 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Wound healing time
Number of days from surgery to complete wound closure (complete epithelialization without need for dressing).Time Frame
From date of surgery until complete epithelialization, assessed daily up to 60 days
Secondary Outcomes (6)
Wound area
Postoperative days 5, 7, and 14
Exudate score
Postoperative days 5, 7, and 14
Pain score (VAS)
Postoperative days 5, 10, and 14
Inflammatory cytokines (TNF-α, IL-6, IL-1β)
Postoperative days 7 and 14
PI3K-Akt-mTOR pathway proteins (p-PI3K, p-Akt, p-mTOR)
Postoperative days 7 and 14
- +1 more secondary outcomes
Study Arms (2)
Tongyangxiao (TYX) group
EXPERIMENTALPatients receive a 15-minute sitz bath once daily with 1500 mL of Tongyangxiao decoction (40°C) from postoperative day 2 for 14 consecutive days. The decoction contains ten herbs: Huangbai (Phellodendron chinense), Kushen (Sophora flavescens), Danggui (Angelica sinensis), Cangzhu (Atractylodes lancea), Qinjiao (Gentiana macrophylla), Xixin (Asarum sieboldii), Fangfeng (Saposhnikovia divaricata), Chuanjiao (Zanthoxylum bungeanum), Mingfan (Alumen), and Mangxiao (Natrii Sulfas).
Potassium permanganate (PP) group
ACTIVE COMPARATORPatients receive a 15-minute sitz bath once daily with 1500 mL of 1:5000 potassium permanganate solution (40°C) from postoperative day 2 for 14 consecutive days.
Interventions
Patients receive a 15-minute sitz bath once daily with 1500 mL of Tongyangxiao decoction (40°C) from postoperative day 2 for 14 consecutive days. The decoction contains ten herbs: Huangbai (Phellodendron chinense), Kushen (Sophora flavescens), Danggui (Angelica sinensis), Cangzhu (Atractylodes lancea), Qinjiao (Gentiana macrophylla), Xixin (Asarum sieboldii), Fangfeng (Saposhnikovia divaricata), Chuanjiao (Zanthoxylum bungeanum), Mingfan (Alumen), and Mangxiao (Natrii Sulfas).
atients receive a 15-minute sitz bath once daily with 1500 mL of 1:5000 potassium permanganate solution (40°C) from postoperative day 2 for 14 consecutive days.
Eligibility Criteria
You may qualify if:
- Age 18 to 65 years
- Diagnosis of low simple anal fistula according to the Chinese expert consensus on diagnosis and treatment of anal fistula (2020 edition)
- Traditional Chinese medicine pattern of damp-heat downward infusion
- Underwent low anal fistulectomy
- No surgical contraindications
You may not qualify if:
- Complex or high anal fistula
- Inflammatory bowel disease, diabetes mellitus, or severe cardiac / liver / renal dysfunction
- Allergy to any component of Tongyangxiao lotion or potassium permanganate
- Pregnancy or lactation
- Participation in another clinical trial within 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yongkang Anlead
Study Sites (1)
the First Affiliated Hospital of Henan University of Chinese Medicine
Zhengzhou, Henan, 450000,, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Chief Physician
Study Record Dates
First Submitted
April 26, 2026
First Posted
May 1, 2026
Study Start
June 1, 2023
Primary Completion
June 30, 2024
Study Completion
June 30, 2024
Last Updated
May 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share